Your browser doesn't support javascript.
loading
Multi-Modality Deep Infarct: Non-invasive identification of infarcted myocardium using composite in-silico-human data learning.
Mehdi, Rana Raza; Kadivar, Nikhil; Mukherjee, Tanmay; Mendiola, Emilio A; Shah, Dipan J; Karniadakis, George; Avazmohammadi, Reza.
Afiliación
  • Mehdi RR; Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
  • Kadivar N; School of Engineering, Brown University, Providence, RI 02912, USA.
  • Mukherjee T; Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
  • Mendiola EA; Department of Biomedical Engineering, Texas A&M University, College Station, TX 77843, USA.
  • Shah DJ; Houston Methodist DeBakey Heart & Vascular Center, Houston, TX 77030, USA.
  • Karniadakis G; School of Engineering, Brown University, Providence, RI 02912, USA.
  • Avazmohammadi R; Division of Applied Mathematics, Brown University, Providence, RI 02912, USA.
bioRxiv ; 2024 Jun 03.
Article en En | MEDLINE | ID: mdl-38895325
ABSTRACT
Myocardial infarction (MI) continues to be a leading cause of death worldwide. The precise quantification of infarcted tissue is crucial to diagnosis, therapeutic management, and post-MI care. Late gadolinium enhancement-cardiac magnetic resonance (LGE-CMR) is regarded as the gold standard for precise infarct tissue localization in MI patients. A fundamental limitation of LGE-CMR is the invasive intravenous introduction of gadolinium-based contrast agents that present potential high-risk toxicity, particularly for individuals with underlying chronic kidney diseases. Herein, we develop a completely non-invasive methodology that identifies the location and extent of an infarct region in the left ventricle via a machine learning (ML) model using only cardiac strains as inputs. In this transformative approach, we demonstrate the remarkable performance of a multi-fidelity ML model that combines rodent-based in-silico-generated training data (low-fidelity) with very limited patient-specific human data (high-fidelity) in predicting LGE ground truth. Our results offer a new paradigm for developing feasible prognostic tools by augmenting synthetic simulation-based data with very small amounts of in-vivo human data. More broadly, the proposed approach can significantly assist with addressing biomedical challenges in healthcare where human data are limited.

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: BioRxiv Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos